title: The antiepileptic drug carbamazepine can cause adrenal insufficiency in patients under hormone replacement therapy for congenital adrenal hyperplasia.
authors.affiliation: Endocrinology Garibaldi-Nesima Hospital, Department of Clinical and Molecular Biomedicine, University of Catania Medical School, Catania, Italy.
authors.forename: Damiano
authors.initials: D
authors.lastname: Gullo
authors.forename: Rossella
authors.initials: R
authors.lastname: Gelsomino
authors.forename: Ilenia
authors.initials: I
authors.lastname: Marturano
authors.forename: Domenico
authors.initials: D
authors.lastname: Restivo
authors.forename: Maria Luisa
authors.initials: ML
authors.lastname: Arpi
authors.forename: Daniela
authors.initials: D
authors.lastname: Leonardi
authors.forename: Giuseppina
authors.initials: G
authors.lastname: Parrinello
authors.forename: Sebastiano
authors.initials: S
authors.lastname: Squatrito
mesh_terms: D000312:Adrenal Hyperplasia, Congenital / Q000150:complications / Q000188:drug therapy*; D000309:Adrenal Insufficiency / Q000209:etiology*; D000328:Adult; D002220:Carbamazepine / Q000009:adverse effects*; D003907:Dexamethasone / Q000627:therapeutic use; D004827:Epilepsy / Q000188:drug therapy; D005438:Fludrocortisone / Q000627:therapeutic use; D020249:Hormone Replacement Therapy; D006801:Humans; D008297:Male; D013255:Steroid 21-Hydroxylase / Q000235:genetics
chemical_list: D002220:Carbamazepine; D003907:Dexamethasone; D013255:Steroid 21-Hydroxylase; D005438:Fludrocortisone